Detalhe da pesquisa
1.
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.
Int J Gynecol Cancer
; 21(1): 58-65, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21178570
2.
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
J Clin Oncol
; 38(32): 3753-3762, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822286
3.
The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
Adv Mater
; 31(4): e1803335, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488990
4.
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
Eur J Cancer
; 70: 111-121, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914241